CHINA GEWANG BIOTECHNOLOGY, INC. - FORM S-1 - EX-23.2 - CONSENT OF WEI, WEI & CO., LLP - November 14, 2016

Attached files

file filename
EX-10.10 - LICENSE AGREEMENT SUPPLEMENT AGREEMENT - CHINA GEWANG BIOTECHNOLOGY, INC.f1010.htm
EX-21.1 - SUBSIDIARIES - CHINA GEWANG BIOTECHNOLOGY, INC.f211.htm
EX-10.9 - LICENSING AGREEMENT - CHINA GEWANG BIOTECHNOLOGY, INC.f109.htm
EX-10.6 - PRODUCT MANUFACTURE AND PURCHASE AGREEMENT - CHINA GEWANG BIOTECHNOLOGY, INC.f106.htm
EX-2.1 - SHARE EXCHANGE AGREEMENT - CHINA GEWANG BIOTECHNOLOGY, INC.f21.htm
S-1 - FORM S-1 - CHINA GEWANG BIOTECHNOLOGY, INC.chinagewangs1new.htm






 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We hereby consent to the inclusion in this registration statement on Form S-1 of our report dated February 29, 2016 relating to the consolidated financial statements of China Gewang Biotechnology, Inc. and Subsidiaries as of November 30, 2015 and 2014 and for the years then ended.


We also consent to the reference to our firm under the caption “Experts” in such registration statement.





/s/ Wei Wei & Co., LLP

Flushing, New York

November 14, 2016







CHINA GEWANG BIOTECHNOLOGY, INC. Reports